🇦🇺 Imlygic in Australia

Imlygic (TALIMOGENE LAHERPAREPVEC) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: likely_approved

Imlygic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Australia

Frequently asked questions

Is Imlygic approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for Imlygic in Australia?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.